SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2026 / Cilt: 53 Sayı: 1

The Relationship Between Blood Groups and Hidradenitis Suppurativa: A Retrospective Evaluation

Kan Grupları ile Hidradenitis Suppurativa Arasındaki İlişki: Retrospektif Değerlendirme

Mustafa Esen(DICLE UNIVERSITY)
Abdullah Demirbaş(Kocaeli University)
Esin Diremsizoglu(Kocaeli University)
Bilal Sula(Dicle University)
Pages
39–45
Publication Date
2026-03-10
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When ABO and Rh blood groups were evaluated together, the overall distribution remained statistically similar across groups (p=0.958).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: This study aims to investigate the potential relationship between ABO blood groups and the incidence of hidradenitis suppurativa.
📊
Key Findings & Data:Methods: This retrospective study included adult patients with clinically diagnosed hidradenitis suppurativa followed at a tertiary dermatology clinic (2019–2023) and healthy controls.
💡
Conclusion & Impact:When ABO and Rh blood groups were evaluated together, the overall distribution remained statistically similar across groups (p=0.958).
🔬Design:Araştırma Makalesi
📍Scope:2019–2023 Verileri
⚙️Variables:Hidradenitis suppurativa · Kan grupları · ABO antijenleri

Abstract

Aims: This study aims to investigate the potential relationship between ABO blood groups and the incidence of hidradenitis suppurativa. Methods: This retrospective study included adult patients with clinically diagnosed hidradenitis suppurativa followed at a tertiary dermatology clinic (2019–2023) and healthy controls. ABO and Rh blood groups were determined using standard agglutination methods. Statistical analyses were performed using chi-square and t-tests Results: A total of 100 patients with hidradenitis suppurativa and 365 healthy controls were included in the analysis. The distribution of ABO blood groups was comparable between the two groups (p=0.650). Blood group A Rh (+) was the most common in both patients (40%) and controls (39.2%), followed by O Rh(+) (30% vs. 27. 1%). Similarly, the Rh factor distribution showed no significant difference, with 89% of patients and 89.6% of controls being Rh positive (p=1.000). When ABO and Rh blood groups were evaluated together, the overall distribution remained statistically similar across groups (p=0.958). Conclusions: This study found no significant association between ABO or Rh blood groups and the occurrence of hidradenitis suppurativa. Further studies with larger and more diverse populations are needed to confirm these findings and investigate potential underlying mechanisms.

Özet

Amaç: Bu çalışma, ABO kan grupları ile hidradenitis suppurativa (HS) görülme sıklığı arasındaki olası ilişkiyi araştırmayı amaçlamaktadır. Yöntemler: Bu retrospektif çalışma, 2019–2023 yılları arasında üçüncü basamak bir dermatoloji kliniğinde takip edilen, klinik olarak HS tanısı almış erişkin hastalar ile sağlıklı kontrolleri içermektedir. ABO ve Rh kan grupları standart aglütinasyon yöntemleriyle belirlenmiştir. İstatistiksel analizler ki-kare ve t-testi kullanılarak yapılmıştır. Bulgular: Analize 100 HS hastası ve 365 sağlıklı kontrol dahil edilmiştir. ABO kan grubu dağılımı iki grup arasında benzer bulunmuştur (p=0,650). Her iki grupta da en sık görülen kan grupları A Rh(+) (sırasıyla %40 ve %39,2) ve O Rh(+) (sırasıyla %30 ve %27,7) olmuştur. Rh faktörü dağılımı da benzer olup, hastaların %89’u ve kontrollerin %89,6’sı Rh pozitif bulunmuştur (p=1,000). ABO ve Rh kan grupları birlikte değerlendirildiğinde de gruplar arasında istatistiksel olarak anlamlı fark saptanmamıştır (p=0,958). Sonuç: Bu çalışma, ABO veya Rh kan grupları ile hidradenitis suppurativa gelişimi arasında anlamlı bir ilişki saptamamıştır. Ancak, bu sonuçların doğrulanması ve hastalığın olası genetik ya da immünolojik bağlantılarının ortaya konması için daha geniş kapsamlı ve çok merkezli çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Esen, M., Demirbaş, A., Diremsizoglu, E., Sula, B. (2026). The Relationship Between Blood Groups and Hidradenitis Suppurativa: A Retrospective Evaluation. Dicle Tıp Dergisi, Cilt: 53 Sayı: 1, 39–45. https://doi.org/10.5798/dicletip.1906407

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (26)

  1. Zouboulis CC, Desai N, Emtestam L, et al. EuropeanS1 guideline for the treatment of hidradenitissuppurativa/acne inversa. JEADV. 2015;29(4):619–44.
  2. Moltrasio C, Tricarico PM, Romagnuolo M, MarzanoAV, Crovella S. Hidradenitis Suppurativa: A Perspectiveon Genetic Factors Involved in the Disease.Biomedicines. 2022;10(8):2039.
  3. Esen M, Demirbas A, Diremsizoglu E. Is Prenatal SexHormone Balance a Risk Factor for the Development ofHidradenitis Suppurativa? Selcuk Med J 2025;41(4):211-216.
  4. Hosoi E. Biological and clinical aspects of ABO bloodgroup system. J Med Investig JMI. 2008;55(3–4):174–82.
  5. Felsenfeld A, Peterson J, Schloss J, Guyer M. Assessingthe quality of the DNA sequence from the HumanGenome Project. Genome Res. 1999;9(1):1–4.
  6. Garratty G. Blood groups and disease: a historicalperspective. Transfus Med Rev. 2000;14(4):291–301.
  7. Scala E, Cacciapuoti S, Garzorz-Stark N, et al.Hidradenitis Suppurativa: Where We Are and WhereWe Are Going. Cells. 2021;10(8):2094.
  8. Reid ME, Lomas-Francis C, Olsson ML. The BloodGroup Antigen FactsBook.3rd ed. Elsevier. 2012;745p.
  9. Kiechl S, Paré G, Barbalic M, et al. Association ofvariation at the ABO locus with circulating levels ofsoluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. CircCardiovasc Genet. 2011;4(6):681-686.
  10. Del Duca E, Morelli P, Bennardo L, Di Raimondo C,Nisticò SP. Cytokine Pathways and InvestigationalTarget Therapies in Hidradenitis Suppurativa. Int J MolSci. 2020;21(22):8436.
  11. Terzi E, Türsen B, Dursun P, et al. The Relationshipbetween ABO Blood Groups and Acne Vulgaris. Saudi JMed Med Sci. 2016;4(1):26–8.
  12. Gürok NG. The correlation between ABO bloodtypes and acne vulgaris severity. J Cosmet Dermatol.2023;22(8):2318–23.
  13. Çildağ S, Kara Y, Şentürk T. ABO blood groups andrheumatic diseases. Eur J Rheumatol. 2017;4(4):250–3.
  14. Türsen B, Terzi E, Bulut B, Türsen Ü, Erdem T. TheRelationship Between ABO Blood Groups and PsoriasisVulgaris. J Turk Acad Dermatol 2015; 9(1): 1591a1.
  15. Dadras MS, Golfeshan A, Younespour S. ABO bloodgroup antigens in patients with psoriasis andpemphigus vulgaris. 2015;18(1).
  16. Valikhani M, Kavand S, Toosi S, Kavand G, Ghiasi M.ABO blood groups, rhesus factor and pemphigus.Indian J Dermatol. 2007;52(4):176.
  17. Valikhani M, Vosooghian L. Association of ABO & Rhblood groups with Vitiligo. Iran J Dermatol.2001;4(2):13–6.
  18. Altunisik N, Turkmen D, Kayhan Tetik B, Sener S.Evaluation of the relationship between androgeneticalopecia and blood groups and Rhesus factor. Int J ClinPract. 2021;75(1):e13647.
  19. İslamoğlu ZGK, Unal M. Is there an association ofABO blood groups and Rhesus factor with alopeciaareata? J Cosmet Dermatol. 2018;17(6):1271–4.
  20. Dahalan NH, Tuan Din SA, Mohamad SMB.Association of ABO blood groups with allergic diseases:a scoping review. BMJ Open. 2020;10(2):e029559.
  21. Gangopadhyay DN, Naskar B, Roy AK. Atopicdermatitis and ABO blood group. Indian J Dermatol.2006;51(1):33.
  22. Kjær C, Larsen LK, Sondrup MA, et al. ABO BloodTypes in Atopic Dermatitis: A Danish Survey. Clin ExpDermatol Ther. 2018; 2018(1):CEDT-144.
  23. Kumar T, Laller S, Malik M, Puri G. Association ofABO blood grouping with oral lichen planus. UniversRes J Dent. 2014;4:93.
  24. Ozturk M, An I. Do blood groups play a role inetiology of rosacea? J Cosmet Dermatol.2020;19(2):400–3.
  25. Shahidi-Dadras M, Sadeghzade-Bazargan A, AzizianZ, Hassani P, Golfeshan A. Evaluation of the AssociationBetween ABO Blood Groups and Lichen Planus. J SkinStem Cell.2016;3(3).
  26. Tamega A de A, Bezerra LVG da SP, Pereira F de P,Miot HA. Blood groups and discoid lupuserythematosus. An Bras Dermatol. 2009;84(5):477–81.